ph3Position Summary /h3pThe Global Program Lead (GPL) will serve as the point of accountability for two hematology assets. The program includes a growing marketed asset for anemia with ongoing pivotal studies and a potential first‑in‑class CELMoD for sickle cell disease. The GPL is responsible for l